• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients: A

Erythropoietin Therapy, Hemoglobin Targets, and Quality of Life in Healthy Hemodialysis Patients: A

来源 :2013年中国肾性贫血治疗专家共识研讨会 | 被引量 : 0次 | 上传用户：x111678
【摘 要】
：
Background and objectives: The effects of different hemoglobin targets when using erythropoiesis-stimulating agents on quality of life are somewhat controversial, and predictors of change in quality o
【作 者】
：
Robert N.Foley Bryan M.Curtis Patrick S.Parfrey 
【机 构】
：
Chronic Disease Research Group and University of Minnesota, Minneapolis, Minnesota
【出 处】
：
2013年中国肾性贫血治疗专家共识研讨会
【发表日期】
：
2012年12期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background and objectives: The effects of different hemoglobin targets when using erythropoiesis-stimulating agents on quality of life are somewhat controversial, and predictors of change in quality of life in endstage renal disease have not been well characterized.
其他文献
Optimal Treatment of Renal Anaemia (OPTA): improving the efficacy and efficiency of renal anaemia th
The medical care of renal anaemia has received much attention over the past decade, as nephrologists have recognized the increased therapeutic value of erythropoiesis-stimulating agents.The European B
会议
epoetinhaemodialysisinfectioninflammationironrenal anaemia
Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disea
Background and objectives: Optimal hemoglobin targets for chronic kidney disease patients receiving erythropoiesisstimulating agents remain controversial.The effects of different hemoglobin targets on
会议
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure
Background.Intravenous iron is a recognized therapy of anaemia in chronic haemodialyzed patients,especially in those receiving erythropoietin (Epo),while its role in the anaemia of pre-dialyzed chroni
会议
anaemiachronic renal failureiron therapypre-dialysis
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline upd
Purpose: To update American Society of Hematology/American Society of Clinical Oncology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.Methods: AnUpdate Co
会议
American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Upd
Purpose To update American Society of Clinical Oncology/American Society of Hematology recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.Methods An Update Com
会议
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patie
Background: Previous analyses report the impact of erythropoiesis-stimulating agents (ESAs) on health-related quality of life across various populations.In this analysis, we review published studies a
会议
Nondialysischronic kidney diseaseerythropoiesis-stimulating agentsenergyphys
Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patie
Background: The role of erythropoiesis-stimulating agents (ESAs) in treating the anemia of chronic kidney disease has been reevaluated in view of recent studies suggesting that the use of these agents
会议
Chronic kidney diseaseerythropoiesis-stimulating agentsepoetin alfaexercise t
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
BACKGROUND Whether correction of anemia in patients with stage 3 or 4 chronic kidney disease improves cardiovascular outcomes is not established.METHODS We randomly assigned 603 patients with an estim
会议
Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Sur
AlthOugh treating anemia of chronic kidney disease by erythropoiesis-stimulating agents (ESA) may improve survival, most studies have examined associations between baseline hemoglobin values and survi
会议
Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients with
It is unclear whether physiologic hemoglobin targets lead to cardiac benefit in incident hemodialysis patients without symptomatic heart disease and left ventricular dilation.In this randomized, doubl
会议